Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Mol Cancer Res. 2018 Aug 28;17(1):140–152. doi: 10.1158/1541-7786.MCR-18-0199

Figure 6. S1P treatment rescues the effect of TVB-3664 on inhibition of the signaling pathway associated with cell migration and invasion.

Figure 6.

Activation of p-Met, p-Fak, p-Akt, RhoA and p-Paxilin was assessed in Pt 2377 PT and Pt 2377 LM primary CRC cells treated with 0.2 μM TVB-3664 (7 d) and 1 μM S1P (20 min) alone or in combination.